VerifiedBiotechnology Research· Founded 2018

Immunoact

Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.

7-day free trial · no credit card

Navi Mumbai, India188(51 to 200)2018immunoact.com LinkedIn

Verified contacts

164

available on Kipplo

LinkedIn employees

188

51 to 200 range

Open roles

—

no listings

Distinct roles

83

indexed titles

Tech stack

0

tools in use

Monthly traffic

7

organic / mo

Sign up free to see all 164 verified contacts at Immunoact

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

164 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 164 verified contacts

Top roles at Immunoact

83 distinct titles indexed · top 10 shown.

13quality control analyst
12scientist i
10associate scientist
6senior scientist
5executive
4assistant manager
4clinical trial assistant
4quality assurance executive
3clinical research associate
3scientist
+73more titles

Sign up to unlock all 164 contacts at Immunoact

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 164 verified contacts at Immunoact

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Immunoact | Kipplo Discover